Objective The aim of this systematic review and meta-analysis study was to determine the
pooled estimate of the effect of antenatal magnesium sulfate (MgSO 4) on intraventricular …

Objective To explore the association between antenatal magnesium sulfate (MgSO4),
mortality and incidence of intraventricular hemorrhage (IVH) in very low birth weight (VLBW) …

Objectives: To determine whether magnesium sulfate (MgSO4) exposure is associated with
a reduced risk for neonatal intraventricular hemorrhage (IVH). Study design: In a …

Background: Intraventricular hemorrhage (IVH) is a common complication seen in premature
infants. Since the brain intraventricular hemorrhage in any degree of risk is an important …

Objective: To test the hypothesis that antenatal magnesium sulfate (MgSO4) has a short term
neuroprotective role in the early neonatal period, when given to women considered at risk …

Background There is widespread, increasing use of magnesium sulphate in obstetric
practice for pre-eclampsia, eclampsia, and preterm fetal neuroprotection; benefit for …

OBJECTIVE: To systematically review rates of neurologic outcomes reported in childhood for
the preterm fetus exposed to antenatal magnesium sulfate. DATA SOURCES: We searched …

Objective To estimate the contributory effect of tocolytic magnesium sulfate (MgSO4)
exposure to intraventricular hemorrhage (IVH) in preterm infants born at 23–31 wks …

Objective: Neonatal periventricular leucomalacia and intraventricular hemorrhage are strong
correlates of cerebral palsy. Our objective was to evaluate the effect of maternal magnesium …

Aims: We aimed to demonstrate the effect of magnesium sulfate for fetal neuroprotection on
maternal and neonatal outcomes of pregnants delivered before 32 weeks. Materials and …